Delphinus Medical Technologies
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Delphinus Medical Technologies sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Delphinus Medical Technologies: 5 sponsored US clinical trials, none currently recruiting.
Delphinus Medical Technologies sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. The most-studied condition in this pipeline is Abnormal Breast Screening, with 2 trials.
Upper-quartile sponsor footprint
Delphinus Medical Technologies sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Delphinus SoftVue™ ROC Reader Study (DMT SV RRS3)
NCT04260620
Delphinus SoftVue™ ROC Reader Study
NCT03972605
Delphinus SoftVue™ ROC Reader Study
NCT03698942
Delphinus SoftVue Prospective Case Collection - ARM 1
NCT03257839
Delphinus SoftVue Prospective Case Collection - ARM 2
NCT02977247
Therapeutic Areas
How the Delphinus Medical Technologies archive is shaped
5 indexed studies, none listed as recruiting (0% open); 5 completed (100%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Abnormal Breast Screening (2 trials), 4 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Delphinus Medical Technologies: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Delphinus Medical Technologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Delphinus Medical Technologies page
5 registered trials is a research-attention snapshot, not an endorsement of Delphinus Medical Technologies or any single study.
- None of Delphinus Medical Technologies's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Abnormal Breast Screening is the condition Delphinus Medical Technologies studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Abnormal Breast Screening trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Delphinus Medical Technologies pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.